MGMarie-Claire Gauduin

Marie-Claire Gauduin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marie-Claire Gauduin has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Edward J. Dick

    Southwest National Primate Research Center

    2 shared publications
  • Mary Salas

    Texas Biomedical Research Institute, Department of Virology and Immunology, San Antonio, TX 78227, USA

    2 shared publications
  • Robert White

    Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, United States

    2 shared publications
  • Ana Cristina Leandro

    Department of Human Genetics, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA

    1 shared publication
  • Gregory Bonello

    Texas Biomedical Research Institute, Department of Virology and Immunology, San Antonio, TX 78227, USA

    1 shared publication
  • Jessica Folwarczny

    Texas Biomedical Research Institute, Department of Virology and Immunology, San Antonio, Texas 78227, USA

    1 shared publication

Latest Publications

  • Open Access

    High-Resolution Quantitative Mapping of Macaque Cervicovaginal Epithelial Thickness: Implications for Mucosal Vaccine Delivery

    by Kathleen L. Vincent, Patrice A. Frost, Massoud Motamedi, Edward J. Dick, Jingna Wei, Jinping Yang, Robert White, Marie-Claire Gauduin

    Vaginal mucosal surfaces naturally offer some protection against sexually transmitted infections (STIs) including Human Immunodeficiency Virus-1, however topical preventative medications or vaccine designed to boost local immune responses can further enhance this protection. We previously developed a novel mucosal vaccine strategy using viral vectors integrated into mouse dermal epithelium to induce virus-specific humoral and cellular immune responses at the site of exposure. Since vaccine integration occurs at the site of cell replication (basal layer 100-400 micrometers below the surface), temporal epithelial thinning during vaccine application, confirmed with high resolution imaging, is desirable. In this study, strategies for vaginal mucosal thinning were evaluated noninvasively using optical coherence tomography (OCT) to map reproductive tract epithelial thickness (ET) in macaques to optimize basal layer access in preparation for future effective intravaginal mucosal vaccination studies. Twelve adolescent female rhesus macaques (5-7kg) were randomly assigned to interventions to induce vaginal mucosal thinning, including cytobrush mechanical abrasion, the chemical surfactant spermicide nonoxynol-9 (N9), the hormonal contraceptive depomedroxyprogesterone acetate (DMPA), or no intervention. Macaques were evaluated at baseline and after interventions using colposcopy, vaginal biopsies, and OCT imaging, which allowed for real-time in vivo visualization and measurement of ET of the mid-vagina, fornices, and cervix. P value ≤0.05 was considered significant. Colposcopy findings included pink, rugated tissue with variable degrees of white-tipped, thickened epithelium. Baseline ET of the fornices was thinner than the cervix and vagina (p<0.05), and mensing macaques had thinner ET at all sites (p<0.001). ET was decreased 1 month after DMPA (p<0.05) in all sites, immediately after mechanical abrasion (p<0.05) in the fornix and cervix, and after two doses of 4% N9 (1.25ml) applied over 14 hrs in the fornix only (p<0.001). Histological assessment of biopsied samples confirmed OCT findings. In summary, OCT imaging allowed for real time assessment of macaque vaginal ET. While varying degrees of thinning were observed after the interventions, limitations with each were noted. ET decreased naturally during menses, which may provide an ideal opportunity for accessing the targeted vaginal mucosal basal layers to achieve the optimum epithelial thickness for intravaginal mucosal vaccination.


  • Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach

    by Robert White, Nicole Chenciner, Gregory Bonello, Mary Salas, Philippe Blancou, Marie-Claire Gauduin


  • Establishment of a neonatal rhesus macaque model to study Mycobacterium tuberculosis infection

    by Magdalena Cepeda, Mary Salas, Jessica Folwarczny, Ana C. Leandro, Vida L. Hodara, Melissa A. de la Garza, Edward J. Dick, Michael Owston, Lisa Y. Armitige, Marie-Claire Gauduin